Cargando…
Tracking HIV Rebound following Latency Reversal Using Barcoded HIV
HIV latency prevents cure of infection with antiretroviral therapy (ART) alone. One strategy for eliminating latently infected cells involves the induction of viral protein expression via latency-reversing agents (LRAs), allowing killing of host cells by viral cytopathic effects or immune effector m...
Autores principales: | Marsden, Matthew D., Zhang, Tian-hao, Du, Yushen, Dimapasoc, Melanie, Soliman, Mohamed S.A., Wu, Xiaomeng, Kim, Jocelyn T., Shimizu, Akira, Schrier, Adam, Wender, Paul A., Sun, Ren, Zack, Jerome A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762775/ https://www.ncbi.nlm.nih.gov/pubmed/33377133 http://dx.doi.org/10.1016/j.xcrm.2020.100162 |
Ejemplares similares
-
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018) -
Latency reversal plus natural killer cells diminish HIV reservoir in vivo
por: Kim, Jocelyn T., et al.
Publicado: (2022) -
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal
por: Moran, Jose A., et al.
Publicado: (2023) -
Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro
por: DeChristopher, Brian A., et al.
Publicado: (2012) -
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication
por: Marsden, Matthew D., et al.
Publicado: (2017)